Rani Therapeutics Holdings Inc
General ticker "RANI" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $51.8M
Rani Therapeutics Holdings Inc does not follow the US Stock Market performance with the rate: -23.8%.
Estimated limits based on current volatility of 6.4%: low 1.28$, high 1.46$
Factors to consider:
- Current price 37.2% below estimated low
- Earnings for 18 months up through Q2 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 estimated range: [3.00$, 7.89$]
- 2023-12-31 to 2024-12-30 estimated range: [2.26$, 5.96$]
Short-term RANI quotes
Long-term RANI plot with estimates
Financial data
| YTD | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|
| Operating Revenue | $0.46MM | $2.72MM | $0.00MM |
| Operating Expenses | $17.01MM | $54.32MM | $63.45MM |
| Operating Income | $-16.54MM | $-51.60MM | $-63.45MM |
| Non-Operating Income | $-0.12MM | $-1.45MM | $0.18MM |
| Interest Expense | $0.12MM | $0.47MM | $1.07MM |
| R&D Expense | $12.04MM | $26.48MM | $36.61MM |
| Income(Loss) | $-16.67MM | $-53.05MM | $-63.27MM |
| Taxes | $0.04MM | $0.04MM | $0.07MM |
| Profit(Loss) | $-16.70MM | $-53.09MM | $-63.34MM |
| Stockholders Equity | $-113.34MM | $47.41MM | $36.85MM |
| Assets | $79.42MM | $124.21MM | $108.03MM |
| Operating Cash Flow | $-14.96MM | $-32.24MM | $-46.52MM |
| Capital expenditure | $1.20MM | $0.51MM | $1.62MM |
| Investing Cash Flow | $-1.20MM | $-0.51MM | $-72.44MM |
| Financing Cash Flow | $72.68MM | $77.15MM | $29.00MM |
| Earnings Per Share* | $-0.85 | $-2.69 | $-2.66 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.